Abstract
Because tissue-type plasminogen activator (tPA), used to treat myocardial infarction, has several disadvantages thought to be connected with its low half-life, mutants of tPA have been prepared with longer half-lives. We have compared the thrombolytic effect of such a mutant, YM866, with that of tPA in copper-coil-induced femoral arterial thrombosis in dogs. One hour after thrombus formation, YM866 was administered by intravenous bolus injection, while tPA was given by the same method or by 60-min infusion under adequate heparinization. Both agents exhibited dose-dependent thrombolysis without systemic fibrinogenolysis. The recanalization rate and recanalization time of YM866 by bolus at 0.2 mg kg-1 were, however, equivalent to those of tPA by infusion at 0.4 mg kg-1 (total dose), whereas the recanalization rate of tPA by bolus was low (0.4 mg kg-1). No significant difference in reocclusion rate, reocclusion time, or patency status after successful thrombolysis was seen. These results suggest that YM866 administered at a lower dose by intravenous bolus injection exerted a thrombolytic effect equivalent to that of tPA by infusion, and that heparin could not prevent reocclusion after successful thrombolysis even under adequate an...Continue Reading
References
Aug 1, 1979·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J L GuesdonS Avrameas
May 1, 1991·Journal of Cardiovascular Pharmacology·S SuzukiC Kawai
Feb 1, 1992·Journal of the American College of Cardiology·U MartinK Strein
Jan 1, 1991·Annals of the New York Academy of Sciences·B S CollerD Knight
May 1, 1990·The American Journal of Cardiology·M I KhanA Maseri
Aug 1, 1990·The Journal of Clinical Investigation·J I WeitzJ Hirsh
Sep 1, 1989·The American Journal of Cardiology·U TebbeK S Herrmann
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·P J Hogg, C M Jackson
Jan 30, 1988·Lancet·M L SimoonsB Meier
Feb 1, 1986·Circulation·H K GoldD Collen
Jan 1, 1988·Annual Review of Medicine·D CollenH K Gold
Sep 1, 1988·Circulation·J A JohnsD Collen
Dec 8, 1988·The New England Journal of Medicine
Jan 1, 1985·Circulation·A J TiefenbrunnB E Sobel
Apr 1, 1985·Circulation·K P Rentrop
May 30, 1983·Biochimica Et Biophysica Acta·R C WohlK C Robbins
Jun 1, 1994·Journal of Cardiovascular Pharmacology·T KawasakiN Ohshima
Sep 1, 1994·Japanese Journal of Pharmacology·M SaitoC Kawai
Jun 12, 1995·European Journal of Pharmacology·S KakuN Satoh
Sep 1, 1995·Circulation·D ZahgerB Cercek
Jun 15, 1995·Circulation·J J CookT M Connolly
Jan 15, 1995·Circulation·N S NicholsonK Broschat
Sep 1, 1993·Japanese Journal of Pharmacology·T KawasakiC Kawai
Oct 1, 1995·Thrombosis Research·T HaraS Kunitada